Email this article to a friend Printable Version FREE Email Newsletter
(NaturalNews) Breast cancer survivors who undergo hormone replacement therapy (HRT) as a treatment for menopause symptoms are significantly more likely to have their cancer recur than survivors who do not use HRT, according to a study conducted by researchers from Kings College London and published in the Journal of the National Cancer Institute.
"The results ... indicate a substantial risk for a new breast cancer event among breast cancer survivors using hormone-replacement therapy," the researchers wrote.
"It seems that harmful side effects of HRT have finally been clearly demonstrated," Kathy Pritchard of Canada's Sunnybrook Odette Cancer Center wrote in an accompanying editorial.
Researchers followed 442 women breast cancer survivors for four or more years. Most of the women were Scandinavian, and half had been given HRT. All the participants had originally participated in a study on HRT that was halted early in 2003, when researchers became concerned that the women undergoing the treatment were at a significantly higher risk of breast cancer recurrence.
That concern was confirmed in the current study, which found a 14 percent higher recurrence rate among women in the HRT group.
Formerly very popular as a way to relieve severe menopause symptoms, HRT fell out of favor in 2002 when evidence emerged that it increased women's risk of breast cancer, ovarian cancer, strokes and other life-threatening health conditions. Since then, health professionals have widely accepted that HRT increases the risk of new cancers in women, but its effects on recurrence have not been well studied.
"Our results ... suggest that hormone therapy not only induces and promotes breast cancer, but may also stimulate the growth of tumor microdeposits in breast cancer survivors," the researchers wrote. "The risk elevation is in line with the evidence from observational studies and randomized trials that [HRT] increases the risk of breast cancer in healthy women."
Get articles like this delivered to you FREE in our popular email newsletter
|

(FREE) Thursday evening, Dec. 3 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with special guests Nick Stern, Sun Warrior Protein & KC Craichy, LivingFuel - "Super Foods, Optimal Health" - Register via email to receive call-in number:
|
|
 Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free! Visit NaturalPedia.com.
|
FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
W.H.O. Declares Global Pandemic Turn FEAR into Confidence!
Listen to the complete 3.5 hour recording on 4 audio CDs of the Health Ranger's Swine Flu Advanced Preparedness Course, covering natural anti-virals, family safety, infrastructure disruptions, quarantine, preparedness gear and much more.
Testimonials:
"Mike Adams' preparedness course turned our fears into confidence. This is POWERFUL information, coming from a trusted source. If you want to save yourself countless hours researching and getting prepared and if you want to do everything in your power to protect your family, I highly recommend the Health Ranger’s Advanced Preparedness Course."
- N. Nelson (Arizona)
"This is packed information no one should miss."
- T. Valenzuela
"Thanks Mike... during this class you covered prevention and preparedness from A to Z with integrity, brave honesty and outstanding knowledge! Thank you for your steadfast, thorough and cool-headed approach to well being. With deep gratitude for your service." - Bev
Available NOW for immediate shipping.
100% satisfaction guarantee
NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
|
|